Louis Tamayo

Chief Financial OfficeratLexeo Therapeutics· In proxies 2024–2025

Pay in FY2025Lexeo Therapeutics stock +50.9% the same year

Louis Tamayo was paid $1.7M in FY2025 (Dec). Lexeo Therapeutics stock rose 50.9% that year.

Pay$100 in the stock at the end of FY23 → $74

Pay is from the Summary Compensation Table of each Lexeo Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

LXEO
Lexeo TherapeuticsPublic company · 2 yr
- Chief Financial Officer2024 – Present · 2 yrStock in role -80%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?